Evidence map›Paper›PMID 42741255›Full record

ArticleFrontiers in epidemiology2026

Trends and forecasting of reported hepatitis B and hepatitis C incidence in Hainan Province, China, 2005-2020.

Jiao Wang, Shibing Li, Cexiong Fu, Yi Su, Hanrong Fu, Yuanyuan Tian, Cheng Lan

Abstract read
In one paragraph

Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiao Wang *Department of Infectious Diseases, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Shibing Li *Department of Pediatric Surgery, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Cexiong FuDepartment of Hepatobiliary and Pancreatic Surgery, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Yi SuDepartment of Infectious Diseases, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Hanrong FuDepartment of Infectious Diseases, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Yuanyuan TianDepartment of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.
Cheng LanDepartment of Gastroenterology, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess long-term trends, seasonality, forecasts, and ecological associations with tourist visits for reported hepatitis B virus (HBV) and hepatitis C virus (HCV) incidence in Hainan Province from 2005 to 2020. Methods: Reported HBV and HCV incidence data from Hainan, national Global Burden of Disease (GBD) estimates for China, and annual tourist visit data were analyzed. Joinpoint regression assessed temporal trends, seasonal-trend decomposition using loess evaluated monthly variation, and seasonal autoregressive integrated moving average models generated forecasts. Spearman rank correlation analysis examined tourism associations, with sensitivity analyses excluding 2020 and using first-differenced and linearly detrended series. Results: Reported HBV incidence declined from 2005 to 2008, increased from 2008 to 2018, and then showed a non-significant decline through 2020; the overall average annual percent change (AAPC) was +3.37%. Reported HCV incidence increased until 2015 and subsequently declined, with an overall AAPC of +14.54%. National GBD estimates showed overall AAPCs of -0.54% for HBV and -1.52% for HCV. No significant differences among calendar months were detected. Under continuation of historical reporting patterns, the annualized projected reported HBV incidence in 2030 was 12.00 per 100,000 population (95% prediction interval: approximately 0.00-121.20), numerically close to the study-defined reference value of 12.20. The corresponding HCV estimate was 22.54 per 100,000 population (approximately 0.00-39.10), approximately 6.4 times the study-defined reference value of 3.55. The wide prediction intervals indicated substantial long-term forecast uncertainty. In 2020, observed mean monthly reported HBV and HCV incidence rates were 27.3% and 9.5% lower than forecasted values, respectively. In raw annual analyses, tourist visits correlated with reported HBV and HCV incidence Conclusion: Reported HBV and HCV incidence in Hainan showed distinct phased changes without significant monthly differences. The forecasts represent projections under historical reporting patterns and should not be interpreted as evidence of progress toward WHO elimination targets. Tourism associations were exploratory and ecological and do not support causal inference. Continued surveillance and strengthened HCV screening, diagnosis, and linkage to treatment remain important.

Indexed as

Hainan Provincehepatitis Bhepatitis Creported incidencetime-series analysis

Identifiers

PMID42741255
PMCPMC13572582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.